Global Intestinal Ascariasis Medicine Supply, Demand and Key Producers, 2023-2029

Global Intestinal Ascariasis Medicine Supply, Demand and Key Producers, 2023-2029

Page: 114

Published Date: 19 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Intestinal Ascariasis Medicine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Intestinal ascariasis is an infection of the small intestine caused by lumbricoides, which is a species of roundworm.

This report studies the global Intestinal Ascariasis Medicine demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Intestinal Ascariasis Medicine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intestinal Ascariasis Medicine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Intestinal Ascariasis Medicine total market, 2018-2029, (USD Million)
Global Intestinal Ascariasis Medicine total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Intestinal Ascariasis Medicine total market, key domestic companies and share, (USD Million)
Global Intestinal Ascariasis Medicine revenue by player and market share 2018-2023, (USD Million)
Global Intestinal Ascariasis Medicine total market by Type, CAGR, 2018-2029, (USD Million)
Global Intestinal Ascariasis Medicine total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Intestinal Ascariasis Medicine market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Actavis, Henan Sino New Energy Material, Bayer HealthCare, Bullvet, Inject Care Parenterals, Endo Pharmaceuticals, Sanofi and Purdue Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intestinal Ascariasis Medicine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Intestinal Ascariasis Medicine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Intestinal Ascariasis Medicine Market, Segmentation by Type
Painkiller
Piperazine Citrate
Complication Treatment Drug
Others

Global Intestinal Ascariasis Medicine Market, Segmentation by Application
Patients With Ulcer Disease
Complication Treatment
Others

Companies Profiled:
Pfizer
Actavis
Henan Sino New Energy Material
Bayer HealthCare
Bullvet
Inject Care Parenterals
Endo Pharmaceuticals
Sanofi
Purdue Pharma
Novartis
Johnson & Johnson
Cipla
Sun Pharmaceutical Industries

Key Questions Answered
1. How big is the global Intestinal Ascariasis Medicine market?
2. What is the demand of the global Intestinal Ascariasis Medicine market?
3. What is the year over year growth of the global Intestinal Ascariasis Medicine market?
4. What is the total value of the global Intestinal Ascariasis Medicine market?
5. Who are the major players in the global Intestinal Ascariasis Medicine market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Intestinal Ascariasis Medicine Introduction
1.2 World Intestinal Ascariasis Medicine Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Intestinal Ascariasis Medicine Total Market by Region (by Headquarter Location)
1.3.1 World Intestinal Ascariasis Medicine Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Intestinal Ascariasis Medicine Market Size (2018-2029)
1.3.3 China Intestinal Ascariasis Medicine Market Size (2018-2029)
1.3.4 Europe Intestinal Ascariasis Medicine Market Size (2018-2029)
1.3.5 Japan Intestinal Ascariasis Medicine Market Size (2018-2029)
1.3.6 South Korea Intestinal Ascariasis Medicine Market Size (2018-2029)
1.3.7 ASEAN Intestinal Ascariasis Medicine Market Size (2018-2029)
1.3.8 India Intestinal Ascariasis Medicine Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Intestinal Ascariasis Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Intestinal Ascariasis Medicine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Intestinal Ascariasis Medicine Consumption Value (2018-2029)
2.2 World Intestinal Ascariasis Medicine Consumption Value by Region
2.2.1 World Intestinal Ascariasis Medicine Consumption Value by Region (2018-2023)
2.2.2 World Intestinal Ascariasis Medicine Consumption Value Forecast by Region (2024-2029)
2.3 United States Intestinal Ascariasis Medicine Consumption Value (2018-2029)
2.4 China Intestinal Ascariasis Medicine Consumption Value (2018-2029)
2.5 Europe Intestinal Ascariasis Medicine Consumption Value (2018-2029)
2.6 Japan Intestinal Ascariasis Medicine Consumption Value (2018-2029)
2.7 South Korea Intestinal Ascariasis Medicine Consumption Value (2018-2029)
2.8 ASEAN Intestinal Ascariasis Medicine Consumption Value (2018-2029)
2.9 India Intestinal Ascariasis Medicine Consumption Value (2018-2029)

3 World Intestinal Ascariasis Medicine Companies Competitive Analysis
3.1 World Intestinal Ascariasis Medicine Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Intestinal Ascariasis Medicine Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Intestinal Ascariasis Medicine in 2022
3.2.3 Global Concentration Ratios (CR8) for Intestinal Ascariasis Medicine in 2022
3.3 Intestinal Ascariasis Medicine Company Evaluation Quadrant
3.4 Intestinal Ascariasis Medicine Market: Overall Company Footprint Analysis
3.4.1 Intestinal Ascariasis Medicine Market: Region Footprint
3.4.2 Intestinal Ascariasis Medicine Market: Company Product Type Footprint
3.4.3 Intestinal Ascariasis Medicine Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Intestinal Ascariasis Medicine Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Intestinal Ascariasis Medicine Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Intestinal Ascariasis Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Intestinal Ascariasis Medicine Consumption Value Comparison
4.2.1 United States VS China: Intestinal Ascariasis Medicine Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Intestinal Ascariasis Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Intestinal Ascariasis Medicine Companies and Market Share, 2018-2023
4.3.1 United States Based Intestinal Ascariasis Medicine Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Intestinal Ascariasis Medicine Revenue, (2018-2023)
4.4 China Based Companies Intestinal Ascariasis Medicine Revenue and Market Share, 2018-2023
4.4.1 China Based Intestinal Ascariasis Medicine Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Intestinal Ascariasis Medicine Revenue, (2018-2023)
4.5 Rest of World Based Intestinal Ascariasis Medicine Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Intestinal Ascariasis Medicine Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Intestinal Ascariasis Medicine Revenue, (2018-2023)

5 Market Analysis by Type
5.1 World Intestinal Ascariasis Medicine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Painkiller
5.2.2 Piperazine Citrate
5.2.3 Complication Treatment Drug
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Intestinal Ascariasis Medicine Market Size by Type (2018-2023)
5.3.2 World Intestinal Ascariasis Medicine Market Size by Type (2024-2029)
5.3.3 World Intestinal Ascariasis Medicine Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
6.1 World Intestinal Ascariasis Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Patients With Ulcer Disease
6.2.2 Complication Treatment
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Intestinal Ascariasis Medicine Market Size by Application (2018-2023)
6.3.2 World Intestinal Ascariasis Medicine Market Size by Application (2024-2029)
6.3.3 World Intestinal Ascariasis Medicine Market Size by Application (2018-2029)

7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Intestinal Ascariasis Medicine Product and Services
7.1.4 Pfizer Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Actavis
7.2.1 Actavis Details
7.2.2 Actavis Major Business
7.2.3 Actavis Intestinal Ascariasis Medicine Product and Services
7.2.4 Actavis Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Actavis Recent Developments/Updates
7.2.6 Actavis Competitive Strengths & Weaknesses
7.3 Henan Sino New Energy Material
7.3.1 Henan Sino New Energy Material Details
7.3.2 Henan Sino New Energy Material Major Business
7.3.3 Henan Sino New Energy Material Intestinal Ascariasis Medicine Product and Services
7.3.4 Henan Sino New Energy Material Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Henan Sino New Energy Material Recent Developments/Updates
7.3.6 Henan Sino New Energy Material Competitive Strengths & Weaknesses
7.4 Bayer HealthCare
7.4.1 Bayer HealthCare Details
7.4.2 Bayer HealthCare Major Business
7.4.3 Bayer HealthCare Intestinal Ascariasis Medicine Product and Services
7.4.4 Bayer HealthCare Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Bayer HealthCare Recent Developments/Updates
7.4.6 Bayer HealthCare Competitive Strengths & Weaknesses
7.5 Bullvet
7.5.1 Bullvet Details
7.5.2 Bullvet Major Business
7.5.3 Bullvet Intestinal Ascariasis Medicine Product and Services
7.5.4 Bullvet Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Bullvet Recent Developments/Updates
7.5.6 Bullvet Competitive Strengths & Weaknesses
7.6 Inject Care Parenterals
7.6.1 Inject Care Parenterals Details
7.6.2 Inject Care Parenterals Major Business
7.6.3 Inject Care Parenterals Intestinal Ascariasis Medicine Product and Services
7.6.4 Inject Care Parenterals Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Inject Care Parenterals Recent Developments/Updates
7.6.6 Inject Care Parenterals Competitive Strengths & Weaknesses
7.7 Endo Pharmaceuticals
7.7.1 Endo Pharmaceuticals Details
7.7.2 Endo Pharmaceuticals Major Business
7.7.3 Endo Pharmaceuticals Intestinal Ascariasis Medicine Product and Services
7.7.4 Endo Pharmaceuticals Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Endo Pharmaceuticals Recent Developments/Updates
7.7.6 Endo Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Sanofi
7.8.1 Sanofi Details
7.8.2 Sanofi Major Business
7.8.3 Sanofi Intestinal Ascariasis Medicine Product and Services
7.8.4 Sanofi Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Sanofi Recent Developments/Updates
7.8.6 Sanofi Competitive Strengths & Weaknesses
7.9 Purdue Pharma
7.9.1 Purdue Pharma Details
7.9.2 Purdue Pharma Major Business
7.9.3 Purdue Pharma Intestinal Ascariasis Medicine Product and Services
7.9.4 Purdue Pharma Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Purdue Pharma Recent Developments/Updates
7.9.6 Purdue Pharma Competitive Strengths & Weaknesses
7.10 Novartis
7.10.1 Novartis Details
7.10.2 Novartis Major Business
7.10.3 Novartis Intestinal Ascariasis Medicine Product and Services
7.10.4 Novartis Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Novartis Recent Developments/Updates
7.10.6 Novartis Competitive Strengths & Weaknesses
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Details
7.11.2 Johnson & Johnson Major Business
7.11.3 Johnson & Johnson Intestinal Ascariasis Medicine Product and Services
7.11.4 Johnson & Johnson Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Johnson & Johnson Recent Developments/Updates
7.11.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.12 Cipla
7.12.1 Cipla Details
7.12.2 Cipla Major Business
7.12.3 Cipla Intestinal Ascariasis Medicine Product and Services
7.12.4 Cipla Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Cipla Recent Developments/Updates
7.12.6 Cipla Competitive Strengths & Weaknesses
7.13 Sun Pharmaceutical Industries
7.13.1 Sun Pharmaceutical Industries Details
7.13.2 Sun Pharmaceutical Industries Major Business
7.13.3 Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Product and Services
7.13.4 Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Sun Pharmaceutical Industries Recent Developments/Updates
7.13.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Intestinal Ascariasis Medicine Industry Chain
8.2 Intestinal Ascariasis Medicine Upstream Analysis
8.3 Intestinal Ascariasis Medicine Midstream Analysis
8.4 Intestinal Ascariasis Medicine Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Intestinal Ascariasis Medicine Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Intestinal Ascariasis Medicine Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Intestinal Ascariasis Medicine Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Intestinal Ascariasis Medicine Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Intestinal Ascariasis Medicine Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Intestinal Ascariasis Medicine Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Intestinal Ascariasis Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Intestinal Ascariasis Medicine Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Intestinal Ascariasis Medicine Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Intestinal Ascariasis Medicine Players in 2022
Table 12. World Intestinal Ascariasis Medicine Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Intestinal Ascariasis Medicine Company Evaluation Quadrant
Table 14. Head Office of Key Intestinal Ascariasis Medicine Player
Table 15. Intestinal Ascariasis Medicine Market: Company Product Type Footprint
Table 16. Intestinal Ascariasis Medicine Market: Company Product Application Footprint
Table 17. Intestinal Ascariasis Medicine Mergers & Acquisitions Activity
Table 18. United States VS China Intestinal Ascariasis Medicine Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Intestinal Ascariasis Medicine Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Intestinal Ascariasis Medicine Companies, Headquarters (States, Country)
Table 21. United States Based Companies Intestinal Ascariasis Medicine Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Intestinal Ascariasis Medicine Revenue Market Share (2018-2023)
Table 23. China Based Intestinal Ascariasis Medicine Companies, Headquarters (Province, Country)
Table 24. China Based Companies Intestinal Ascariasis Medicine Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Intestinal Ascariasis Medicine Revenue Market Share (2018-2023)
Table 26. Rest of World Based Intestinal Ascariasis Medicine Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Intestinal Ascariasis Medicine Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Intestinal Ascariasis Medicine Revenue Market Share (2018-2023)
Table 29. World Intestinal Ascariasis Medicine Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Intestinal Ascariasis Medicine Market Size by Type (2018-2023) & (USD Million)
Table 31. World Intestinal Ascariasis Medicine Market Size by Type (2024-2029) & (USD Million)
Table 32. World Intestinal Ascariasis Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Intestinal Ascariasis Medicine Market Size by Application (2018-2023) & (USD Million)
Table 34. World Intestinal Ascariasis Medicine Market Size by Application (2024-2029) & (USD Million)
Table 35. Pfizer Basic Information, Area Served and Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer Intestinal Ascariasis Medicine Product and Services
Table 38. Pfizer Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Pfizer Recent Developments/Updates
Table 40. Pfizer Competitive Strengths & Weaknesses
Table 41. Actavis Basic Information, Area Served and Competitors
Table 42. Actavis Major Business
Table 43. Actavis Intestinal Ascariasis Medicine Product and Services
Table 44. Actavis Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Actavis Recent Developments/Updates
Table 46. Actavis Competitive Strengths & Weaknesses
Table 47. Henan Sino New Energy Material Basic Information, Area Served and Competitors
Table 48. Henan Sino New Energy Material Major Business
Table 49. Henan Sino New Energy Material Intestinal Ascariasis Medicine Product and Services
Table 50. Henan Sino New Energy Material Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Henan Sino New Energy Material Recent Developments/Updates
Table 52. Henan Sino New Energy Material Competitive Strengths & Weaknesses
Table 53. Bayer HealthCare Basic Information, Area Served and Competitors
Table 54. Bayer HealthCare Major Business
Table 55. Bayer HealthCare Intestinal Ascariasis Medicine Product and Services
Table 56. Bayer HealthCare Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Bayer HealthCare Recent Developments/Updates
Table 58. Bayer HealthCare Competitive Strengths & Weaknesses
Table 59. Bullvet Basic Information, Area Served and Competitors
Table 60. Bullvet Major Business
Table 61. Bullvet Intestinal Ascariasis Medicine Product and Services
Table 62. Bullvet Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Bullvet Recent Developments/Updates
Table 64. Bullvet Competitive Strengths & Weaknesses
Table 65. Inject Care Parenterals Basic Information, Area Served and Competitors
Table 66. Inject Care Parenterals Major Business
Table 67. Inject Care Parenterals Intestinal Ascariasis Medicine Product and Services
Table 68. Inject Care Parenterals Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Inject Care Parenterals Recent Developments/Updates
Table 70. Inject Care Parenterals Competitive Strengths & Weaknesses
Table 71. Endo Pharmaceuticals Basic Information, Area Served and Competitors
Table 72. Endo Pharmaceuticals Major Business
Table 73. Endo Pharmaceuticals Intestinal Ascariasis Medicine Product and Services
Table 74. Endo Pharmaceuticals Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Endo Pharmaceuticals Recent Developments/Updates
Table 76. Endo Pharmaceuticals Competitive Strengths & Weaknesses
Table 77. Sanofi Basic Information, Area Served and Competitors
Table 78. Sanofi Major Business
Table 79. Sanofi Intestinal Ascariasis Medicine Product and Services
Table 80. Sanofi Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Sanofi Recent Developments/Updates
Table 82. Sanofi Competitive Strengths & Weaknesses
Table 83. Purdue Pharma Basic Information, Area Served and Competitors
Table 84. Purdue Pharma Major Business
Table 85. Purdue Pharma Intestinal Ascariasis Medicine Product and Services
Table 86. Purdue Pharma Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Purdue Pharma Recent Developments/Updates
Table 88. Purdue Pharma Competitive Strengths & Weaknesses
Table 89. Novartis Basic Information, Area Served and Competitors
Table 90. Novartis Major Business
Table 91. Novartis Intestinal Ascariasis Medicine Product and Services
Table 92. Novartis Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Novartis Recent Developments/Updates
Table 94. Novartis Competitive Strengths & Weaknesses
Table 95. Johnson & Johnson Basic Information, Area Served and Competitors
Table 96. Johnson & Johnson Major Business
Table 97. Johnson & Johnson Intestinal Ascariasis Medicine Product and Services
Table 98. Johnson & Johnson Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. Johnson & Johnson Competitive Strengths & Weaknesses
Table 101. Cipla Basic Information, Area Served and Competitors
Table 102. Cipla Major Business
Table 103. Cipla Intestinal Ascariasis Medicine Product and Services
Table 104. Cipla Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Cipla Recent Developments/Updates
Table 106. Sun Pharmaceutical Industries Basic Information, Area Served and Competitors
Table 107. Sun Pharmaceutical Industries Major Business
Table 108. Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Product and Services
Table 109. Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 110. Global Key Players of Intestinal Ascariasis Medicine Upstream (Raw Materials)
Table 111. Intestinal Ascariasis Medicine Typical Customers
List of Figure
Figure 1. Intestinal Ascariasis Medicine Picture
Figure 2. World Intestinal Ascariasis Medicine Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Intestinal Ascariasis Medicine Total Market Size (2018-2029) & (USD Million)
Figure 4. World Intestinal Ascariasis Medicine Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Intestinal Ascariasis Medicine Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Intestinal Ascariasis Medicine Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Intestinal Ascariasis Medicine Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Intestinal Ascariasis Medicine Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Intestinal Ascariasis Medicine Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Intestinal Ascariasis Medicine Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Intestinal Ascariasis Medicine Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Intestinal Ascariasis Medicine Revenue (2018-2029) & (USD Million)
Figure 13. Intestinal Ascariasis Medicine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Intestinal Ascariasis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 16. World Intestinal Ascariasis Medicine Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Intestinal Ascariasis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 18. China Intestinal Ascariasis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Intestinal Ascariasis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Intestinal Ascariasis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Intestinal Ascariasis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Intestinal Ascariasis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 23. India Intestinal Ascariasis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Intestinal Ascariasis Medicine by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Intestinal Ascariasis Medicine Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Intestinal Ascariasis Medicine Markets in 2022
Figure 27. United States VS China: Intestinal Ascariasis Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Intestinal Ascariasis Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Intestinal Ascariasis Medicine Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Intestinal Ascariasis Medicine Market Size Market Share by Type in 2022
Figure 31. Painkiller
Figure 32. Piperazine Citrate
Figure 33. Complication Treatment Drug
Figure 34. Others
Figure 35. World Intestinal Ascariasis Medicine Market Size Market Share by Type (2018-2029)
Figure 36. World Intestinal Ascariasis Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Intestinal Ascariasis Medicine Market Size Market Share by Application in 2022
Figure 38. Patients With Ulcer Disease
Figure 39. Complication Treatment
Figure 40. Others
Figure 41. Intestinal Ascariasis Medicine Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Pfizer
Actavis
Henan Sino New Energy Material
Bayer HealthCare
Bullvet
Inject Care Parenterals
Endo Pharmaceuticals
Sanofi
Purdue Pharma
Novartis
Johnson & Johnson
Cipla
Sun Pharmaceutical Industries
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Intestinal Ascariasis Medicine Supply, Demand and Key Producers, 2023-2029

Global Intestinal Ascariasis Medicine Supply, Demand and Key Producers, 2023-2029

Page: 114

Published Date: 19 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Intestinal Ascariasis Medicine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Intestinal ascariasis is an infection of the small intestine caused by lumbricoides, which is a species of roundworm.

This report studies the global Intestinal Ascariasis Medicine demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Intestinal Ascariasis Medicine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intestinal Ascariasis Medicine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Intestinal Ascariasis Medicine total market, 2018-2029, (USD Million)
Global Intestinal Ascariasis Medicine total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Intestinal Ascariasis Medicine total market, key domestic companies and share, (USD Million)
Global Intestinal Ascariasis Medicine revenue by player and market share 2018-2023, (USD Million)
Global Intestinal Ascariasis Medicine total market by Type, CAGR, 2018-2029, (USD Million)
Global Intestinal Ascariasis Medicine total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Intestinal Ascariasis Medicine market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Actavis, Henan Sino New Energy Material, Bayer HealthCare, Bullvet, Inject Care Parenterals, Endo Pharmaceuticals, Sanofi and Purdue Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intestinal Ascariasis Medicine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Intestinal Ascariasis Medicine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Intestinal Ascariasis Medicine Market, Segmentation by Type
Painkiller
Piperazine Citrate
Complication Treatment Drug
Others

Global Intestinal Ascariasis Medicine Market, Segmentation by Application
Patients With Ulcer Disease
Complication Treatment
Others

Companies Profiled:
Pfizer
Actavis
Henan Sino New Energy Material
Bayer HealthCare
Bullvet
Inject Care Parenterals
Endo Pharmaceuticals
Sanofi
Purdue Pharma
Novartis
Johnson & Johnson
Cipla
Sun Pharmaceutical Industries

Key Questions Answered
1. How big is the global Intestinal Ascariasis Medicine market?
2. What is the demand of the global Intestinal Ascariasis Medicine market?
3. What is the year over year growth of the global Intestinal Ascariasis Medicine market?
4. What is the total value of the global Intestinal Ascariasis Medicine market?
5. Who are the major players in the global Intestinal Ascariasis Medicine market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Intestinal Ascariasis Medicine Introduction
1.2 World Intestinal Ascariasis Medicine Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Intestinal Ascariasis Medicine Total Market by Region (by Headquarter Location)
1.3.1 World Intestinal Ascariasis Medicine Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Intestinal Ascariasis Medicine Market Size (2018-2029)
1.3.3 China Intestinal Ascariasis Medicine Market Size (2018-2029)
1.3.4 Europe Intestinal Ascariasis Medicine Market Size (2018-2029)
1.3.5 Japan Intestinal Ascariasis Medicine Market Size (2018-2029)
1.3.6 South Korea Intestinal Ascariasis Medicine Market Size (2018-2029)
1.3.7 ASEAN Intestinal Ascariasis Medicine Market Size (2018-2029)
1.3.8 India Intestinal Ascariasis Medicine Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Intestinal Ascariasis Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Intestinal Ascariasis Medicine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Intestinal Ascariasis Medicine Consumption Value (2018-2029)
2.2 World Intestinal Ascariasis Medicine Consumption Value by Region
2.2.1 World Intestinal Ascariasis Medicine Consumption Value by Region (2018-2023)
2.2.2 World Intestinal Ascariasis Medicine Consumption Value Forecast by Region (2024-2029)
2.3 United States Intestinal Ascariasis Medicine Consumption Value (2018-2029)
2.4 China Intestinal Ascariasis Medicine Consumption Value (2018-2029)
2.5 Europe Intestinal Ascariasis Medicine Consumption Value (2018-2029)
2.6 Japan Intestinal Ascariasis Medicine Consumption Value (2018-2029)
2.7 South Korea Intestinal Ascariasis Medicine Consumption Value (2018-2029)
2.8 ASEAN Intestinal Ascariasis Medicine Consumption Value (2018-2029)
2.9 India Intestinal Ascariasis Medicine Consumption Value (2018-2029)

3 World Intestinal Ascariasis Medicine Companies Competitive Analysis
3.1 World Intestinal Ascariasis Medicine Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Intestinal Ascariasis Medicine Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Intestinal Ascariasis Medicine in 2022
3.2.3 Global Concentration Ratios (CR8) for Intestinal Ascariasis Medicine in 2022
3.3 Intestinal Ascariasis Medicine Company Evaluation Quadrant
3.4 Intestinal Ascariasis Medicine Market: Overall Company Footprint Analysis
3.4.1 Intestinal Ascariasis Medicine Market: Region Footprint
3.4.2 Intestinal Ascariasis Medicine Market: Company Product Type Footprint
3.4.3 Intestinal Ascariasis Medicine Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Intestinal Ascariasis Medicine Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Intestinal Ascariasis Medicine Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Intestinal Ascariasis Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Intestinal Ascariasis Medicine Consumption Value Comparison
4.2.1 United States VS China: Intestinal Ascariasis Medicine Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Intestinal Ascariasis Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Intestinal Ascariasis Medicine Companies and Market Share, 2018-2023
4.3.1 United States Based Intestinal Ascariasis Medicine Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Intestinal Ascariasis Medicine Revenue, (2018-2023)
4.4 China Based Companies Intestinal Ascariasis Medicine Revenue and Market Share, 2018-2023
4.4.1 China Based Intestinal Ascariasis Medicine Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Intestinal Ascariasis Medicine Revenue, (2018-2023)
4.5 Rest of World Based Intestinal Ascariasis Medicine Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Intestinal Ascariasis Medicine Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Intestinal Ascariasis Medicine Revenue, (2018-2023)

5 Market Analysis by Type
5.1 World Intestinal Ascariasis Medicine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Painkiller
5.2.2 Piperazine Citrate
5.2.3 Complication Treatment Drug
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Intestinal Ascariasis Medicine Market Size by Type (2018-2023)
5.3.2 World Intestinal Ascariasis Medicine Market Size by Type (2024-2029)
5.3.3 World Intestinal Ascariasis Medicine Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
6.1 World Intestinal Ascariasis Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Patients With Ulcer Disease
6.2.2 Complication Treatment
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Intestinal Ascariasis Medicine Market Size by Application (2018-2023)
6.3.2 World Intestinal Ascariasis Medicine Market Size by Application (2024-2029)
6.3.3 World Intestinal Ascariasis Medicine Market Size by Application (2018-2029)

7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Intestinal Ascariasis Medicine Product and Services
7.1.4 Pfizer Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Actavis
7.2.1 Actavis Details
7.2.2 Actavis Major Business
7.2.3 Actavis Intestinal Ascariasis Medicine Product and Services
7.2.4 Actavis Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Actavis Recent Developments/Updates
7.2.6 Actavis Competitive Strengths & Weaknesses
7.3 Henan Sino New Energy Material
7.3.1 Henan Sino New Energy Material Details
7.3.2 Henan Sino New Energy Material Major Business
7.3.3 Henan Sino New Energy Material Intestinal Ascariasis Medicine Product and Services
7.3.4 Henan Sino New Energy Material Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Henan Sino New Energy Material Recent Developments/Updates
7.3.6 Henan Sino New Energy Material Competitive Strengths & Weaknesses
7.4 Bayer HealthCare
7.4.1 Bayer HealthCare Details
7.4.2 Bayer HealthCare Major Business
7.4.3 Bayer HealthCare Intestinal Ascariasis Medicine Product and Services
7.4.4 Bayer HealthCare Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Bayer HealthCare Recent Developments/Updates
7.4.6 Bayer HealthCare Competitive Strengths & Weaknesses
7.5 Bullvet
7.5.1 Bullvet Details
7.5.2 Bullvet Major Business
7.5.3 Bullvet Intestinal Ascariasis Medicine Product and Services
7.5.4 Bullvet Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Bullvet Recent Developments/Updates
7.5.6 Bullvet Competitive Strengths & Weaknesses
7.6 Inject Care Parenterals
7.6.1 Inject Care Parenterals Details
7.6.2 Inject Care Parenterals Major Business
7.6.3 Inject Care Parenterals Intestinal Ascariasis Medicine Product and Services
7.6.4 Inject Care Parenterals Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Inject Care Parenterals Recent Developments/Updates
7.6.6 Inject Care Parenterals Competitive Strengths & Weaknesses
7.7 Endo Pharmaceuticals
7.7.1 Endo Pharmaceuticals Details
7.7.2 Endo Pharmaceuticals Major Business
7.7.3 Endo Pharmaceuticals Intestinal Ascariasis Medicine Product and Services
7.7.4 Endo Pharmaceuticals Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Endo Pharmaceuticals Recent Developments/Updates
7.7.6 Endo Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Sanofi
7.8.1 Sanofi Details
7.8.2 Sanofi Major Business
7.8.3 Sanofi Intestinal Ascariasis Medicine Product and Services
7.8.4 Sanofi Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Sanofi Recent Developments/Updates
7.8.6 Sanofi Competitive Strengths & Weaknesses
7.9 Purdue Pharma
7.9.1 Purdue Pharma Details
7.9.2 Purdue Pharma Major Business
7.9.3 Purdue Pharma Intestinal Ascariasis Medicine Product and Services
7.9.4 Purdue Pharma Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Purdue Pharma Recent Developments/Updates
7.9.6 Purdue Pharma Competitive Strengths & Weaknesses
7.10 Novartis
7.10.1 Novartis Details
7.10.2 Novartis Major Business
7.10.3 Novartis Intestinal Ascariasis Medicine Product and Services
7.10.4 Novartis Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Novartis Recent Developments/Updates
7.10.6 Novartis Competitive Strengths & Weaknesses
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Details
7.11.2 Johnson & Johnson Major Business
7.11.3 Johnson & Johnson Intestinal Ascariasis Medicine Product and Services
7.11.4 Johnson & Johnson Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Johnson & Johnson Recent Developments/Updates
7.11.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.12 Cipla
7.12.1 Cipla Details
7.12.2 Cipla Major Business
7.12.3 Cipla Intestinal Ascariasis Medicine Product and Services
7.12.4 Cipla Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Cipla Recent Developments/Updates
7.12.6 Cipla Competitive Strengths & Weaknesses
7.13 Sun Pharmaceutical Industries
7.13.1 Sun Pharmaceutical Industries Details
7.13.2 Sun Pharmaceutical Industries Major Business
7.13.3 Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Product and Services
7.13.4 Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Sun Pharmaceutical Industries Recent Developments/Updates
7.13.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Intestinal Ascariasis Medicine Industry Chain
8.2 Intestinal Ascariasis Medicine Upstream Analysis
8.3 Intestinal Ascariasis Medicine Midstream Analysis
8.4 Intestinal Ascariasis Medicine Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Intestinal Ascariasis Medicine Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Intestinal Ascariasis Medicine Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Intestinal Ascariasis Medicine Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Intestinal Ascariasis Medicine Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Intestinal Ascariasis Medicine Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Intestinal Ascariasis Medicine Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Intestinal Ascariasis Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Intestinal Ascariasis Medicine Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Intestinal Ascariasis Medicine Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Intestinal Ascariasis Medicine Players in 2022
Table 12. World Intestinal Ascariasis Medicine Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Intestinal Ascariasis Medicine Company Evaluation Quadrant
Table 14. Head Office of Key Intestinal Ascariasis Medicine Player
Table 15. Intestinal Ascariasis Medicine Market: Company Product Type Footprint
Table 16. Intestinal Ascariasis Medicine Market: Company Product Application Footprint
Table 17. Intestinal Ascariasis Medicine Mergers & Acquisitions Activity
Table 18. United States VS China Intestinal Ascariasis Medicine Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Intestinal Ascariasis Medicine Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Intestinal Ascariasis Medicine Companies, Headquarters (States, Country)
Table 21. United States Based Companies Intestinal Ascariasis Medicine Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Intestinal Ascariasis Medicine Revenue Market Share (2018-2023)
Table 23. China Based Intestinal Ascariasis Medicine Companies, Headquarters (Province, Country)
Table 24. China Based Companies Intestinal Ascariasis Medicine Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Intestinal Ascariasis Medicine Revenue Market Share (2018-2023)
Table 26. Rest of World Based Intestinal Ascariasis Medicine Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Intestinal Ascariasis Medicine Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Intestinal Ascariasis Medicine Revenue Market Share (2018-2023)
Table 29. World Intestinal Ascariasis Medicine Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Intestinal Ascariasis Medicine Market Size by Type (2018-2023) & (USD Million)
Table 31. World Intestinal Ascariasis Medicine Market Size by Type (2024-2029) & (USD Million)
Table 32. World Intestinal Ascariasis Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Intestinal Ascariasis Medicine Market Size by Application (2018-2023) & (USD Million)
Table 34. World Intestinal Ascariasis Medicine Market Size by Application (2024-2029) & (USD Million)
Table 35. Pfizer Basic Information, Area Served and Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer Intestinal Ascariasis Medicine Product and Services
Table 38. Pfizer Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Pfizer Recent Developments/Updates
Table 40. Pfizer Competitive Strengths & Weaknesses
Table 41. Actavis Basic Information, Area Served and Competitors
Table 42. Actavis Major Business
Table 43. Actavis Intestinal Ascariasis Medicine Product and Services
Table 44. Actavis Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Actavis Recent Developments/Updates
Table 46. Actavis Competitive Strengths & Weaknesses
Table 47. Henan Sino New Energy Material Basic Information, Area Served and Competitors
Table 48. Henan Sino New Energy Material Major Business
Table 49. Henan Sino New Energy Material Intestinal Ascariasis Medicine Product and Services
Table 50. Henan Sino New Energy Material Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Henan Sino New Energy Material Recent Developments/Updates
Table 52. Henan Sino New Energy Material Competitive Strengths & Weaknesses
Table 53. Bayer HealthCare Basic Information, Area Served and Competitors
Table 54. Bayer HealthCare Major Business
Table 55. Bayer HealthCare Intestinal Ascariasis Medicine Product and Services
Table 56. Bayer HealthCare Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Bayer HealthCare Recent Developments/Updates
Table 58. Bayer HealthCare Competitive Strengths & Weaknesses
Table 59. Bullvet Basic Information, Area Served and Competitors
Table 60. Bullvet Major Business
Table 61. Bullvet Intestinal Ascariasis Medicine Product and Services
Table 62. Bullvet Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Bullvet Recent Developments/Updates
Table 64. Bullvet Competitive Strengths & Weaknesses
Table 65. Inject Care Parenterals Basic Information, Area Served and Competitors
Table 66. Inject Care Parenterals Major Business
Table 67. Inject Care Parenterals Intestinal Ascariasis Medicine Product and Services
Table 68. Inject Care Parenterals Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Inject Care Parenterals Recent Developments/Updates
Table 70. Inject Care Parenterals Competitive Strengths & Weaknesses
Table 71. Endo Pharmaceuticals Basic Information, Area Served and Competitors
Table 72. Endo Pharmaceuticals Major Business
Table 73. Endo Pharmaceuticals Intestinal Ascariasis Medicine Product and Services
Table 74. Endo Pharmaceuticals Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Endo Pharmaceuticals Recent Developments/Updates
Table 76. Endo Pharmaceuticals Competitive Strengths & Weaknesses
Table 77. Sanofi Basic Information, Area Served and Competitors
Table 78. Sanofi Major Business
Table 79. Sanofi Intestinal Ascariasis Medicine Product and Services
Table 80. Sanofi Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Sanofi Recent Developments/Updates
Table 82. Sanofi Competitive Strengths & Weaknesses
Table 83. Purdue Pharma Basic Information, Area Served and Competitors
Table 84. Purdue Pharma Major Business
Table 85. Purdue Pharma Intestinal Ascariasis Medicine Product and Services
Table 86. Purdue Pharma Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Purdue Pharma Recent Developments/Updates
Table 88. Purdue Pharma Competitive Strengths & Weaknesses
Table 89. Novartis Basic Information, Area Served and Competitors
Table 90. Novartis Major Business
Table 91. Novartis Intestinal Ascariasis Medicine Product and Services
Table 92. Novartis Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Novartis Recent Developments/Updates
Table 94. Novartis Competitive Strengths & Weaknesses
Table 95. Johnson & Johnson Basic Information, Area Served and Competitors
Table 96. Johnson & Johnson Major Business
Table 97. Johnson & Johnson Intestinal Ascariasis Medicine Product and Services
Table 98. Johnson & Johnson Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. Johnson & Johnson Competitive Strengths & Weaknesses
Table 101. Cipla Basic Information, Area Served and Competitors
Table 102. Cipla Major Business
Table 103. Cipla Intestinal Ascariasis Medicine Product and Services
Table 104. Cipla Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Cipla Recent Developments/Updates
Table 106. Sun Pharmaceutical Industries Basic Information, Area Served and Competitors
Table 107. Sun Pharmaceutical Industries Major Business
Table 108. Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Product and Services
Table 109. Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 110. Global Key Players of Intestinal Ascariasis Medicine Upstream (Raw Materials)
Table 111. Intestinal Ascariasis Medicine Typical Customers
List of Figure
Figure 1. Intestinal Ascariasis Medicine Picture
Figure 2. World Intestinal Ascariasis Medicine Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Intestinal Ascariasis Medicine Total Market Size (2018-2029) & (USD Million)
Figure 4. World Intestinal Ascariasis Medicine Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Intestinal Ascariasis Medicine Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Intestinal Ascariasis Medicine Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Intestinal Ascariasis Medicine Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Intestinal Ascariasis Medicine Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Intestinal Ascariasis Medicine Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Intestinal Ascariasis Medicine Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Intestinal Ascariasis Medicine Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Intestinal Ascariasis Medicine Revenue (2018-2029) & (USD Million)
Figure 13. Intestinal Ascariasis Medicine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Intestinal Ascariasis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 16. World Intestinal Ascariasis Medicine Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Intestinal Ascariasis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 18. China Intestinal Ascariasis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Intestinal Ascariasis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Intestinal Ascariasis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Intestinal Ascariasis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Intestinal Ascariasis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 23. India Intestinal Ascariasis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Intestinal Ascariasis Medicine by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Intestinal Ascariasis Medicine Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Intestinal Ascariasis Medicine Markets in 2022
Figure 27. United States VS China: Intestinal Ascariasis Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Intestinal Ascariasis Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Intestinal Ascariasis Medicine Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Intestinal Ascariasis Medicine Market Size Market Share by Type in 2022
Figure 31. Painkiller
Figure 32. Piperazine Citrate
Figure 33. Complication Treatment Drug
Figure 34. Others
Figure 35. World Intestinal Ascariasis Medicine Market Size Market Share by Type (2018-2029)
Figure 36. World Intestinal Ascariasis Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Intestinal Ascariasis Medicine Market Size Market Share by Application in 2022
Figure 38. Patients With Ulcer Disease
Figure 39. Complication Treatment
Figure 40. Others
Figure 41. Intestinal Ascariasis Medicine Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Pfizer
Actavis
Henan Sino New Energy Material
Bayer HealthCare
Bullvet
Inject Care Parenterals
Endo Pharmaceuticals
Sanofi
Purdue Pharma
Novartis
Johnson & Johnson
Cipla
Sun Pharmaceutical Industries
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now